Boehringer's Gilotrif Gets FDA Approval for NSCLC

Source: PharmaManufacturing.com

Jul 16, 2013

PharmaTimes.com

Boehringer Ingelheim announces approval of its first oncology drug after regulators in the USA gave the green light to Gilotrif for late-stage non-small cell lung cancer. Read the full story